Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -15.94%14.8B | -1.70%83.15B | -3.77%17.61B | 7.86%84.58B | -19.08%23.45B | 45.90%21.41B | 33.00%21.43B | -1.91%18.3B | 7.78%78.42B | 66.23%28.98B |
| Cost of revenue | -0.69%6.79B | 5.02%30.76B | 8.62%6.84B | 37.40%29.29B | 32.21%7.73B | 5.86%6.65B | 48.00%8.61B | 86.97%6.3B | -3.79%21.32B | 1.14%5.85B |
| Gross profit | -25.64%8.01B | -5.25%52.39B | -10.28%10.77B | -3.16%55.29B | -32.06%15.71B | 75.89%14.76B | 24.54%12.82B | -21.49%12B | 12.84%57.1B | 98.57%23.13B |
| Operating expense | -12.12%4.43B | -24.36%20.27B | 12.27%5.04B | 49.17%26.8B | 7.78%7.53B | 123.27%8.3B | 78.19%6.47B | 23.88%4.49B | 11.76%17.97B | 64.55%6.99B |
| Selling and administrative expenses | ---- | ---- | 12.27%5.04B | 49.17%26.8B | 7.78%7.53B | 123.27%8.3B | 78.19%6.47B | 23.88%4.49B | 11.76%17.97B | 64.55%6.99B |
| -General and administrative expense | ---- | ---- | 12.27%5.04B | 49.17%26.8B | 7.78%7.53B | 123.27%8.3B | 78.19%6.47B | 23.88%4.49B | 11.76%17.97B | 64.55%6.99B |
| Operating profit | -37.55%3.57B | 12.72%32.12B | -23.76%5.72B | -27.18%28.5B | -49.32%8.18B | 38.21%6.46B | -4.71%6.35B | -35.61%7.51B | 13.34%39.13B | 118.11%16.14B |
| Net non-operating interest income (expenses) | -52.33%2.34B | 7.19%15.64B | 66.51%4.92B | 4.59%14.59B | 20.16%4.62B | 17.00%4.16B | -17.81%2.86B | -3.90%2.95B | 148.86%13.95B | 194.33%3.84B |
| Non-operating interest income | -52.33%2.34B | 7.19%15.64B | 66.51%4.92B | 4.59%14.59B | 20.16%4.62B | 17.00%4.16B | -17.81%2.86B | -3.90%2.95B | 148.86%13.95B | 194.33%3.84B |
| Net investment income | -131.33%-151M | 19.03%1.74B | -38.91%482M | 67.35%1.46B | 449.00%349M | 142.26%284M | -92.38%39M | -30.36%789M | -36.46%873M | -129.24%-100M |
| Gain(Loss) on financial instruments designated as cash flow hedges | -39.77%3.35B | -138.61%-3.04B | 98.54%5.57B | 2,380.00%7.87B | -95.08%397M | 105.28%175M | 451.33%4.49B | 173.44%2.8B | 95.11%-345M | 598.45%8.07B |
| Gain(Loss) on derecognition of available-for-sale financial assets | -117.56%-367M | 174.40%3.61B | 206.90%2.09B | 66.49%-4.86B | 103.73%191M | 85.77%-717M | -431.28%-5.01B | 120.14%681M | -197.57%-14.49B | -216.27%-5.12B |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 0 | -752.38%-411M | -106.35%-4M | 210.53%63M | 63M | ||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 29.21%-63M | ---- |
| Less:Write off | --0 | --0 | ---- | --411M | --4M | ---- | ---- | ---- | --0 | --0 |
| Other non-operating income (expenses) | 118.42%14M | 95.16%-88M | -58.33%-76M | -334.71%-1.82B | -1,028.57%-1.82B | 3,600.00%259M | -240.94%-210M | -111.35%-48M | 227.05%775M | 110.31%196M |
| Income before tax | -53.11%8.77B | 10.28%49.99B | 27.34%18.7B | 13.43%45.33B | -48.39%11.91B | 1,398.22%10.22B | -0.78%8.51B | 61.64%14.69B | -17.84%39.96B | 133.70%23.08B |
| Income tax | -46.77%2.7B | 7.13%12.36B | 22.49%5.07B | 27.79%11.54B | -57.30%2.4B | 543.18%2.73B | 34.80%2.27B | 77.09%4.14B | -32.01%9.03B | 100.11%5.63B |
| Net income | -55.48%6.07B | 11.35%37.63B | 29.25%13.64B | 9.24%33.79B | -45.53%9.51B | 4,478.95%7.49B | -9.50%6.24B | 56.33%10.55B | -12.51%30.94B | 147.07%17.46B |
| Net income continuous operations | -55.47%6.07B | 11.35%37.63B | 29.25%13.64B | 9.24%33.79B | -45.53%9.51B | 4,478.36%7.49B | -9.47%6.24B | 56.30%10.55B | -12.51%30.94B | 147.07%17.46B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -55.48%6.07B | 11.35%37.63B | 29.25%13.64B | 9.24%33.79B | -45.53%9.51B | 4,478.95%7.49B | -9.50%6.24B | 56.33%10.55B | -12.51%30.94B | 147.07%17.46B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -55.48%6.07B | 11.35%37.63B | 29.25%13.64B | 9.24%33.79B | -45.53%9.51B | 4,478.95%7.49B | -9.50%6.24B | 56.33%10.55B | -12.51%30.94B | 147.07%17.46B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -55.47%19.23 | 11.28%119.14 | 29.05%43.18 | 9.02%107.06 | -45.67%30.11 | 4,410.91%23.71 | -9.68%19.78 | 56.14%33.46 | -8.46%98.2 | 149.86%55.42 |
| Diluted earnings per share | -52.59%19.2 | 13.96%113.65 | 29.64%40.5 | 9.33%99.73 | -45.92%28.12 | 2,472.04%22.06 | -9.76%18.31 | 57.30%31.24 | -13.00%91.22 | 155.15%52 |
| Dividend per share | 0 | 11.11%60 | 0 | 8.00%54 | 8.00%54 | 0 | 0 | 0 | -7.41%50 | -7.41%50 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |